Index -
P/E -
EPS (ttm) -1.79
Insider Own 7.36%
Shs Outstand 38.15M
Perf Week 7.93%
Market Cap 465.41M
Forward P/E 13.92
EPS next Y 0.87
Insider Trans -0.06%
Shs Float 35.57M
Perf Month -16.24%
Income -56.05M
PEG -
EPS next Q -0.29
Inst Own 64.02%
Short Float 25.60%
Perf Quarter -23.34%
Sales 217.65M
P/S 2.14
EPS this Y 77.88%
Inst Trans -2.49%
Short Ratio 3.19
Perf Half Y 60.53%
Book/sh 5.63
P/B 2.15
EPS next Y 1037.46%
ROA -14.06%
Short Interest 9.11M
Perf Year 453.42%
Cash/sh 1.43
P/C 8.45
EPS next 5Y 13.00%
ROE -28.06%
52W Range 1.60 - 24.75
Perf YTD -37.27%
Dividend Est. -
P/FCF -
EPS past 5Y -74.26%
ROI -18.95%
52W High -51.03%
Beta 2.08
Dividend TTM -
Quick Ratio 1.16
Sales past 5Y -2.51%
Gross Margin 26.72%
52W Low 657.50%
ATR (14) 0.93
Dividend Ex-Date -
Current Ratio 1.85
EPS Y/Y TTM 24.78%
Oper. Margin -19.00%
RSI (14) 41.50
Volatility 9.14% 5.85%
Employees 2149
Debt/Eq 0.56
Sales Y/Y TTM -2.32%
Profit Margin -25.75%
Recom 2.00
Target Price 18.00
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q 46.71%
Payout -
Rel Volume 0.74
Prev Close 11.66
Sales Surprise -7.27%
EPS Surprise 6566.67%
Sales Q/Q -1.84%
Earnings Feb 22 AMC
Avg Volume 2.86M
Price 12.12
SMA20 -6.44%
SMA50 -19.64%
SMA200 -9.76%
Trades
Volume 2,103,796
Change 3.95%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-24 Downgrade
B. Riley Securities
Buy → Neutral
$22 → $16
Jan-30-24 Initiated
Rosenblatt
Buy
$23
Dec-13-23 Reiterated
B. Riley Securities
Buy
$13.50 → $22
Aug-04-23 Upgrade
B. Riley Securities
Neutral → Buy
$2.50 → $11.50
Feb-25-22 Downgrade
Craig Hallum
Hold → Sell
$7 → $2.50
Mar-02-21 Downgrade
Needham
Buy → Hold
Nov-09-20 Reiterated
Needham
Buy
$22 → $9
Nov-06-20 Reiterated
B. Riley Securities
Neutral
$11 → $9
Oct-26-20 Upgrade
Northland Capital
Under Perform → Market Perform
$10
Aug-07-20 Upgrade
Craig Hallum
Sell → Hold
Aug-07-20 Reiterated
Needham
Buy
$15 → $22
Jul-21-20 Upgrade
Needham
Hold → Buy
$15
May-08-20 Downgrade
Rosenblatt
Buy → Neutral
$11.50 → $10
Nov-05-19 Upgrade
Rosenblatt
Neutral → Buy
$10 → $13
Oct-22-19 Downgrade
JP Morgan
Neutral → Underweight
$11
Jul-29-19 Initiated
JP Morgan
Neutral
$11
Jun-27-19 Upgrade
Rosenblatt
Sell → Neutral
$10
Feb-22-19 Downgrade
Raymond James
Outperform → Mkt Perform
Feb-22-19 Downgrade
Needham
Buy → Hold
Feb-22-19 Downgrade
DA Davidson
Buy → Neutral
$42 → $16
Show Previous Ratings
Apr-18-24 04:10PM
Mar-25-24 09:00AM
Mar-18-24 07:00PM
07:00PM
Feb-23-24 10:22AM
09:21AM
Loading…
09:21AM
07:07AM
(Thomson Reuters StreetEvents)
Feb-22-24 08:52PM
05:20PM
(Associated Press Finance)
04:43PM
04:24PM
04:15PM
04:10PM
Feb-01-24 04:10PM
Jan-30-24 01:04PM
05:01PM
Loading…
Jan-18-24 05:01PM
Dec-22-23 07:00AM
Dec-14-23 07:00AM
Dec-12-23 07:00AM
Dec-01-23 12:00PM
08:00AM
Nov-30-23 08:46AM
Nov-21-23 08:00AM
(Investor's Business Daily) -7.81%
Nov-10-23 10:41AM
09:23AM
(Thomson Reuters StreetEvents)
07:00AM
Nov-09-23 04:20PM
(Associated Press Finance)
04:06PM
04:05PM
Oct-26-23 10:33AM
04:10PM
Loading…
Oct-19-23 04:10PM
Oct-05-23 07:00AM
Oct-02-23 07:00AM
Sep-29-23 09:40AM
Sep-25-23 09:33AM
Sep-19-23 07:00AM
Sep-14-23 09:39PM
Sep-13-23 09:40AM
Sep-01-23 12:30PM
Aug-28-23 04:10PM
09:40AM
Aug-18-23 01:02PM
Aug-10-23 09:40AM
Aug-04-23 02:21PM
10:54AM
Aug-03-23 05:35PM
04:32PM
04:10PM
Jul-31-23 07:00AM
Jul-28-23 04:45PM
Jul-26-23 01:30PM
Jul-20-23 07:19AM
Jul-13-23 04:10PM
Jul-06-23 09:51AM
Jul-05-23 04:15PM
Jun-28-23 04:15PM
Jun-20-23 07:00AM
May-25-23 04:05PM
May-22-23 07:00AM
May-09-23 06:06AM
May-04-23 08:05PM
06:58PM
04:10PM
Apr-13-23 04:10PM
Mar-29-23 06:26AM
Mar-17-23 09:40AM
Mar-01-23 09:40AM
08:50AM
Feb-24-23 06:34AM
(Thomson Reuters StreetEvents) -14.14%
Feb-23-23 07:00PM
04:10PM
Feb-16-23 05:26AM
Feb-02-23 04:10PM
Dec-05-22 09:00AM
Nov-14-22 05:14AM
Nov-09-22 06:00AM
Nov-03-22 07:15PM
04:10PM
Oct-13-22 04:10PM
Sep-18-22 07:45PM
(American City Business Journals)
Sep-16-22 06:59AM
Sep-15-22 04:10PM
Aug-05-22 11:30AM
Aug-04-22 06:45PM
04:10PM
Jul-14-22 04:10PM
Jul-05-22 12:00PM
May-18-22 04:10PM
May-05-22 06:45PM
04:10PM
May-03-22 05:55PM
Apr-14-22 04:10PM
Feb-25-22 01:00AM
Feb-24-22 05:40PM
04:10PM
Feb-17-22 03:02PM
Feb-09-22 05:45PM
Jan-31-22 04:16AM
Jan-18-22 04:10PM
Nov-23-21 04:10PM
Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lin Che-Wei Director Mar 18 '24 Buy 12.70 31,370 398,283 220,133 Mar 18 04:05 PM Lin Chih-Hsiang (Thompson) President and CEO Mar 18 '24 Buy 12.66 11,780 149,169 1,218,160 Mar 18 04:04 PM Yeh William H Director Mar 18 '24 Buy 12.75 8,000 102,000 207,255 Mar 19 04:20 PM Yeh William H Director Feb 27 '24 Buy 15.29 10,000 152,900 199,255 Feb 28 04:02 PM Murry Stefan J. Chief Financial Officer Jan 16 '24 Sale 17.08 20,000 341,592 200,488 Jan 18 04:01 PM Chang Hung-Lun (Fred) *** See Remarks Jan 05 '24 Option Exercise 13.84 1,100 15,224 217,481 Jan 09 04:01 PM Murry Stefan J. Chief Financial Officer Dec 20 '23 Option Exercise 13.84 5,000 69,200 223,815 Dec 21 04:01 PM Yeh Shu-Hua (Joshua) *** See Remarks Dec 15 '23 Sale 23.71 20 474 251,331 Dec 18 06:21 PM Yeh Shu-Hua (Joshua) *** See Remarks Dec 14 '23 Sale 22.39 42,779 958,023 251,351 Dec 18 06:21 PM Lin Chih-Hsiang (Thompson) President and CEO Dec 11 '23 Option Exercise 13.84 30,000 415,200 1,257,832 Dec 13 04:01 PM Yeh Shu-Hua (Joshua) *** See Remarks Dec 07 '23 Option Exercise 13.84 5,000 69,200 298,567 Dec 11 04:01 PM Lin Chih-Hsiang (Thompson) President and CEO Sep 14 '23 Buy 9.79 15,000 146,901 1,252,471 Sep 14 05:07 PM Yeh Shu-Hua (Joshua) *** See Remarks Sep 12 '23 Option Exercise 9.96 12,000 119,520 313,404 Sep 14 04:01 PM Lin Chih-Hsiang (Thompson) President and CEO Sep 06 '23 Buy 12.44 5,964 74,165 1,237,471 Sep 06 04:01 PM Lin Chih-Hsiang (Thompson) President and CEO Aug 31 '23 Option Exercise 9.96 67,348 670,786 1,283,599 Sep 05 07:09 PM Murry Stefan J. Chief Financial Officer Aug 31 '23 Option Exercise 9.96 11,000 109,560 233,130 Sep 05 07:09 PM Murry Stefan J. Chief Financial Officer Aug 22 '23 Sale 15.88 15,000 238,216 222,130 Aug 22 04:03 PM Yeh William H Director Aug 21 '23 Sale 15.22 10,000 152,200 189,255 Aug 22 04:04 PM Lin Chih-Hsiang (Thompson) President and CEO Aug 18 '23 Buy 12.36 14,438 178,519 1,217,335 Aug 18 04:16 PM Lin Chih-Hsiang (Thompson) President and CEO Aug 17 '23 Buy 12.42 5,562 69,097 1,202,897 Aug 18 04:16 PM Lin Chih-Hsiang (Thompson) President and CEO Aug 11 '23 Buy 12.60 15,802 199,173 1,197,335 Aug 14 07:42 AM Chang Hung-Lun (Fred) *** See Remarks Aug 10 '23 Sale 14.08 13,637 192,050 221,854 Aug 11 04:02 PM Kuo David C *** See Remarks Aug 10 '23 Sale 13.73 10,000 137,305 127,878 Aug 11 04:02 PM Yeh Shu-Hua (Joshua) *** See Remarks Aug 09 '23 Sale 12.10 45,000 544,311 301,404 Aug 10 07:33 AM Murry Stefan J. Chief Financial Officer Aug 08 '23 Sale 11.82 60,000 709,134 237,130 Aug 10 07:33 AM Chang Hung-Lun (Fred) *** See Remarks Aug 08 '23 Sale 12.07 32,346 390,261 235,491 Aug 10 07:32 AM Kuo David C *** See Remarks Aug 08 '23 Sale 11.86 14,535 172,398 137,878 Aug 10 07:33 AM
Index RUT
P/E -
EPS (ttm) -2.19
Insider Own 15.00%
Shs Outstand 54.48M
Perf Week -13.49%
Market Cap 36.13M
Forward P/E -
EPS next Y -1.02
Insider Trans -1.01%
Shs Float 46.46M
Perf Month -26.78%
Income -118.51M
PEG -
EPS next Q -0.40
Inst Own 46.61%
Short Float 5.55%
Perf Quarter 16.99%
Sales 20.97M
P/S 1.72
EPS this Y 50.23%
Inst Trans -0.34%
Short Ratio 3.93
Perf Half Y -53.12%
Book/sh 1.05
P/B 0.63
EPS next Y 6.61%
ROA -76.94%
Short Interest 2.58M
Perf Year -84.26%
Cash/sh 1.85
P/C 0.36
EPS next 5Y -
ROE -109.80%
52W Range 0.50 - 4.67
Perf YTD -11.04%
Dividend Est. -
P/FCF -
EPS past 5Y -1.20%
ROI -118.22%
52W High -85.85%
Beta 0.76
Dividend TTM -
Quick Ratio 4.43
Sales past 5Y 115.17%
Gross Margin 69.32%
52W Low 32.20%
ATR (14) 0.08
Dividend Ex-Date -
Current Ratio 4.54
EPS Y/Y TTM -37.39%
Oper. Margin -579.43%
RSI (14) 36.07
Volatility 9.57% 10.00%
Employees 55
Debt/Eq 0.76
Sales Y/Y TTM -49.92%
Profit Margin -565.21%
Recom 1.40
Target Price 5.12
Option/Short Yes / Yes
LT Debt/Eq 0.76
EPS Q/Q -5.19%
Payout -
Rel Volume 0.53
Prev Close 0.69
Sales Surprise -68.12%
EPS Surprise -32.29%
Sales Q/Q -7.88%
Earnings Mar 04 AMC
Avg Volume 655.74K
Price 0.66
SMA20 -19.52%
SMA50 -18.20%
SMA200 -54.25%
Trades
Volume 350,793
Change -4.20%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-08-23 Downgrade
BofA Securities
Neutral → Underperform
$13 → $6
Mar-08-22 Upgrade
JP Morgan
Neutral → Overweight
$17 → $20
Nov-01-21 Resumed
Canaccord Genuity
Buy
$33
Aug-03-21 Initiated
JP Morgan
Neutral
$16
Apr-21-20 Reiterated
H.C. Wainwright
Buy
$30 → $33
Aug-12-19 Reiterated
H.C. Wainwright
Buy
$31 → $30
May-29-19 Reiterated
Laidlaw
Buy
$26 → $32
Feb-06-19 Resumed
Jefferies
Buy
$22
Jan-15-19 Initiated
BofA/Merrill
Neutral
$19
Sep-21-18 Initiated
Cantor Fitzgerald
Overweight
Sep-13-18 Initiated
Jefferies
Buy
$30
Aug-08-18 Reiterated
Stifel
Buy
$22 → $26
Jun-28-18 Reiterated
H.C. Wainwright
Buy
$24 → $26
Mar-12-18 Resumed
H.C. Wainwright
Buy
$22
Feb-12-18 Upgrade
Janney
Neutral → Buy
Jan-19-18 Initiated
Seaport Global Securities
Buy
$27
Jun-30-17 Reiterated
Stifel
Buy
$24 → $20
Jun-30-17 Reiterated
Laidlaw
Buy
$35 → $30
Jun-30-17 Downgrade
Janney
Buy → Neutral
Mar-28-17 Reiterated
Laidlaw
Buy
$20 → $35
Show Previous Ratings
Apr-02-24 07:00AM
Mar-07-24 07:00AM
06:40AM
Mar-05-24 09:07AM
07:51AM
(Thomson Reuters StreetEvents)
08:51PM
Loading…
Mar-04-24 08:51PM
05:10PM
04:21PM
(Associated Press Finance)
04:01PM
Feb-12-24 04:01PM
Jan-22-24 10:19AM
07:00AM
Dec-18-23 07:00AM
Nov-14-23 11:04AM
08:48AM
(Thomson Reuters StreetEvents)
06:00PM
Loading…
Nov-13-23 06:00PM
04:15PM
(Associated Press Finance)
04:01PM
Nov-09-23 11:38AM
Nov-06-23 10:00AM
Nov-02-23 07:00AM
Oct-23-23 07:00AM
Sep-25-23 07:00AM
Sep-05-23 07:00AM
Aug-10-23 02:53AM
Aug-08-23 05:54AM
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
04:09PM
(Associated Press Finance)
04:01PM
Aug-03-23 07:00AM
07:00AM
Loading…
Aug-02-23 07:00AM
Jul-24-23 07:00AM
Jun-14-23 01:37PM
Jun-13-23 06:30AM
Jun-02-23 06:46PM
Jun-01-23 07:00AM
May-30-23 06:34PM
May-25-23 06:40AM
May-18-23 04:53PM
02:00AM
May-16-23 11:02AM
(Thomson Reuters StreetEvents) +7.23%
May-15-23 05:15PM
04:07PM
04:01PM
May-04-23 09:38AM
May-01-23 07:00AM
Apr-26-23 08:00PM
Apr-10-23 07:00AM
Apr-07-23 08:41AM
Mar-14-23 07:00AM
Mar-11-23 07:19AM
Mar-08-23 06:59AM
Mar-07-23 10:46AM
10:02AM
(Thomson Reuters StreetEvents)
09:43AM
08:05AM
Mar-06-23 07:39PM
05:15PM
04:01PM
Feb-27-23 10:00AM
Feb-21-23 07:00AM
Feb-15-23 05:11AM
Feb-08-23 05:00PM
Jan-17-23 07:00AM
Jan-03-23 07:00AM
Dec-29-22 05:53AM
Nov-29-22 07:30AM
Nov-09-22 06:08AM
Nov-07-22 05:35PM
04:01PM
Nov-04-22 08:46AM
Nov-03-22 07:00AM
Nov-02-22 10:01AM
07:00AM
Oct-31-22 10:00AM
Oct-30-22 08:51AM
Oct-24-22 07:00AM
Oct-18-22 09:55AM
Oct-10-22 04:05PM
Sep-28-22 07:00AM
Sep-20-22 09:47AM
Sep-12-22 07:00AM
Sep-08-22 02:27PM
08:15AM
Sep-06-22 07:00AM
Aug-24-22 07:00AM
Aug-22-22 07:00AM
Aug-19-22 01:00AM
Aug-08-22 05:15PM
04:01PM
Aug-04-22 08:48AM
Aug-03-22 07:00AM
Aug-01-22 04:01PM
Jul-28-22 09:14AM
Jul-22-22 06:39AM
Jun-30-22 10:19AM
07:00AM
Jun-06-22 11:46AM
May-23-22 07:04AM
May-17-22 07:00AM
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Apr 05 '24 Sale 0.83 2,753 2,285 88,247 Apr 09 04:21 PM Goncalves Joana CHIEF MEDICAL OFFICER Apr 05 '24 Sale 0.83 2,753 2,285 53,365 Apr 09 04:22 PM Posner Christopher PRESIDENT AND CEO Feb 29 '24 Sale 0.89 5,834 5,192 180,521 Mar 04 04:19 PM Goncalves Joana CHIEF MEDICAL OFFICER Feb 29 '24 Sale 0.89 3,293 2,931 56,118 Mar 04 04:13 PM Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Feb 29 '24 Sale 0.89 3,293 2,931 91,000 Mar 04 04:24 PM Posner Christopher PRESIDENT AND CEO Feb 08 '24 Sale 0.53 35,575 18,855 186,355 Feb 12 05:10 PM Posner Christopher PRESIDENT AND CEO Feb 01 '24 Sale 0.55 4,981 2,740 221,930 Feb 05 04:26 PM Posner Christopher President and CEO Nov 02 '23 Sale 1.22 3,796 4,631 164,411 Nov 03 04:37 PM Posner Christopher President and CEO Aug 03 '23 Sale 3.07 4,307 13,222 168,207 Aug 04 05:21 PM Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Jun 23 '23 Sale 3.51 2,993 10,505 153,747 Jun 27 04:08 PM Goncalves Joana Chief Medical Officer Jun 23 '23 Sale 3.51 2,723 9,558 53,681 Jun 27 04:07 PM Terrillion Scott Sec'y; Chief Compliance & G.C. Jun 23 '23 Sale 3.51 2,483 8,715 88,563 Jun 27 04:09 PM Posner Christopher President and CEO May 05 '23 Sale 4.40 3,869 17,024 172,514 May 09 04:22 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite